Biologics Spine BioRestorative Therapies Announces First Patient Enrolled for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD) byChris StewartJune 30, 2022
Biologics Spine BioRestorative Therapies Announces Clinical Trial Contract with Second Site for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD) byChris StewartJune 22, 2022
Biologics Spine BioRestorative Therapies Announces Clinical Site Initiation for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD) byJosh SandbergJune 13, 2022
Spine Centinel Spine Clinical Study for Total Disc Replacement for 2-Level Symptomatic Cervical Disc Disease byJosh SandbergMay 24, 2022
Spine NuVasive Simplify Cervical Disc Two-level Data Published in Journal of Neurosurgery: Spine byChris StewartApril 21, 2022
Spine Top Stories Spine Innovations Marks Milestone — Over 20,000 ESP Spinal Discs Implanted — as Global Demand Grows byJosh SandbergMarch 28, 2022
Spine 100th U.S. Patient Treated In IDE Clinical Trials Of Baguera® C Cervical Disc Prosthesis byChris StewartNovember 17, 2021
Spine NuVasive Simplify Cervical Disc Data Published In International Journal Of Spine Surgery byChris StewartSeptember 9, 2021
Neuro Robotics Spine Top Stories U.S. Spine Surgeon Dr. Todd Lanman Launches Advanced Disc Replacement Spinal Restoration Center, Pioneering Leading-Edge Motion Preservation Solutions byJosh SandbergJune 7, 2021
Regulatory Spine MCRA CRO Assists Simplify Medical, Recently Acquired by NuVasive, on FDA-Approval for Two Level use of its Cervical Disc byJosh SandbergMay 12, 2021
